Related Experiment Videos
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia
Michael J Swartz1, Surinder K Batra, Grish C Varshney
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
American Journal of Clinical Pathology
|July 2, 2002
Summary
MUC4 expression increases with pancreatic intraepithelial neoplasia (PanIN) progression, supporting its role in pancreatic cancer development. This study details MUC4
Area of Science:
- Oncology
- Gastroenterology
- Molecular Pathology
Background:
- Pancreatic adenocarcinoma development is modeled after the colon adenoma-carcinoma sequence, involving precursor lesions called PanINs.
- The apomucin MUC4 is highly expressed in invasive pancreatic adenocarcinoma but not in normal pancreatic tissue.
Purpose of the Study:
- To investigate the expression patterns of MUC4 in PanIN lesions.
- To assess MUC4's role in the progression model of pancreatic adenocarcinoma.
Main Methods:
- Immunohistochemical analysis of 71 PanIN lesions using a novel MUC4 monoclonal antibody.
- Evaluation of MUC4 expression in PanIN-1, PanIN-2, PanIN-3, and invasive adenocarcinomas.
Main Results:
- MUC4 expression was detected in 17% of PanIN-1, 36% of PanIN-2, and 85% of PanIN-3 lesions.
- High MUC4 expression (89%) was observed in invasive adenocarcinomas.
- MUC4 was also detected in some nonneoplastic pancreatic lesions, including chronic pancreatitis and squamous metaplasia.
Conclusions:
- MUC4 expression increases progressively through PanIN stages, supporting its role in pancreatic cancer development.
- These findings reinforce the PanIN progression model for pancreatic adenocarcinoma.